Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease. (2015)

First Author: Ersek A

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci59987

PubMed Identifier: 25915583

Publication URI: http://europepmc.org/abstract/MED/25915583

Type: Journal Article/Review

Volume: 125

Parent Publication: The Journal of clinical investigation

Issue: 6

ISSN: 0021-9738